Atlas Trials

Vanguard Research Group

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Vanguard Research Group

RecordFirmDate
An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients (NCT06923891)Vanguard Research Group2025-04-16

Track Vanguard Research Group automatically

Every clearance here is in the API, with alerts when new ones post.